Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

By sjmartinez • May 26, 2023

Bhattacharya D, Aronsohn A, Price J, Lo Re V; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2023 May 25:ciad319. doi: 10.1093/cid/ciad319. Epub ahead of print. PMID: 37229695.

Tags: Direct-acting antivirals, HCV guidance, HCV prevention, HCV screening, HCV treatment, Infectious Diseases, Publications

Prompt Initiation of Maternal Antiretroviral Therapy After HIV Seroconversion in Pregnancy Effectively Prevents Vertical Transmission and Other Adverse Infant Outcomes

Sundar KG, Yang LZ, Cambou MC, Varella IRS, Melo MG, Segura ER, Ziegler ÂP, Santos BR, Nielsen-Saines K. Prompt Initiation of Maternal Antiretroviral Therapy After[...]

Factors Associated With PrEP Utilization and Access in the United States

David HM, Martin T, Wells A, Little SJ, Mehta S. Factors Associated With PrEP Utilization and Access in the United States. AIDS Educ Prev. 2024[...]

The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment

Cosgrove SE, Miller LG. The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment? JAMA Netw Open. 2024 Dec 2;7(12):e2451300. doi: 10.1001/jamanetworkopen.2024.51300. PMID: 39705037.